Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukaemia treated with idelalisib Meeting Abstract


Authors: Hillmen, P.; Brown, J.; Zelenetz, A.; Furman, R.; Lamanna, N.; Mato, A.; Montillo, M.; O'Brien, S.; Dreiling, L.; Dubowy, R.; Kim, Y.; Munugalavada, V.; Robak, T.
Abstract Title: Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukaemia treated with idelalisib
Meeting Title: 58th Annual Scientific Meeting of the British Society for Haematology
Keywords: risk factors; cll; idelalisib; chronic lymphocytic leukaemia; transaminase
Journal Title: British Journal of Haematology
Volume: 181
Issue: Suppl. 1
Meeting Dates: 2018 Apr 16-18
Meeting Location: Liverpool, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2018-04-01
Start Page: 86
Language: English
ACCESSION: WOS:000430117900109
PROVIDER: wos
PUBMED: 29658101
DOI: 10.1111/bjh.15226
Notes: Meeting Abstract: BSH18-PO-078 -- 58th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 16-18, 2018 -- Liverpool, ENGLAND -- 1 -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz